Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,467 JPY | -0.50% | +0.10% | -19.46% |
26/04 | Ichigo Office REIT Investment Secures Fixed Rates for 2 Billion Loans In Swap Deal | MT |
26/04 | Japan Metropolitan Fund Investment Sets Interest Rates for 3 Billion Yen Loan | MT |
Strengths
- Growth progress expectations are rather promising. Indeed, sales are expected to rise sharply in the coming years.
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The company's share price in relation to its net book value makes it look relatively cheap.
Weaknesses
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
- The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Banks
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-19.46% | 1.92B | B | ||
+12.73% | 551B | C+ | ||
+12.38% | 295B | C+ | ||
+13.35% | 249B | C+ | ||
+22.43% | 210B | C | ||
+12.90% | 170B | B- | ||
+20.81% | 169B | B- | ||
+12.13% | 165B | C+ | ||
+3.47% | 144B | B- | ||
-12.77% | 139B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- 8304 Stock
- Ratings Aozora Bank, Ltd.